Vial: difference between revisions
Diff·revision 27 → 28·18:59, 21 Dec 2024
Difference between revision 27 and revision 28 of Vial. 7 lines changed; the page grew by 160 bytes.
| Revision 27 — 17:35, 14 Dec 2024 CategoryBot (talk) bot: update parent category chain 14,338 bytes +1,425 | Revision 28 — 18:59, 21 Dec 2024 SupplyWatchSuri (talk) ce, tighten prose 14,498 bytes +160 | ||
|---|---|---|---|
| 123 | <ref name="fda2011">US Food and Drug Administration. "Advisory to Drug Manufacturers: Formation of Glass Lamellae in Certain Injectable Drugs" (March 2011).</ref> | 123 | <ref name="fda2011">US Food and Drug Administration. "Advisory to Drug Manufacturers: Formation of Glass Lamellae in Certain Injectable Drugs" (March 2011).</ref> |
| 124 | 124 | ||
| + | 125 | == See also == | |
| + | 126 | * [[Multi-dose vial]] | |
| + | 127 | * [[Vial filling and stoppering]] | |
| + | 128 | * [[Lyophilisation]] | |
| + | 129 | * [[Beyond-use date]] | |
| + | 130 | * [[Reconstitution of lyophilised peptides]] | |
| + | 131 | ||
| 125 | {{DEFAULTSORT:Vial}} | 132 | {{DEFAULTSORT:Vial}} |
| 126 | [[Category:Fill and finish]] | 133 | [[Category:Fill and finish]] |